From Molecule to Market

Listed below are just some of our long term partners from around the world.

Talk to us for a more in-depth understanding of these and other companies we collaborate with and the specific sourcing solutions we can offer you.

Click on a company logo below for a quick overview of their capabilities.

formosa Bioindustria savior Antibiotice
iasis novocat grindex Apotex Pharmachem Inc.
signa themis corden chr olesen
irix ELPEN viwit zach
ICROM systematix   NCPC
 

ANTIBIOTICE, Romania

ANTIBIOTICE was founded in 1955 and is located in Iasi, Romania. ANTIBIOTICE has a large portfolio of over 150 drugs and has extensive R&D and production capabilities. The company has a very large fermentation capacity mainly devoted to Nystatin and are very interested in custom projects from R&D to commercial.

The product quality of ANTIBIOTICE is backed by certifications including: Good Manufacturing Practice (GMP) for all 8 streams of manufacturing, European Pharmacopoeia Certificate of Suitability (COS), and US Food and Drug Administration (FDA) inspection.

In addition, the company has several large manufacturing facilities for dosage forms including oral, topical, injectable, and suppository production and is supported by a large local sales force detailing Ethical and Generic products. Back To Top

APOTEX PHARMACHEM, Canada

APOTEX PHARMACHEM, a member of the APOTEX group of companies, is a global fully integrated API R&D and manufacturing organization with its headquarters in Brantford, Ontario, Canada.

Currently employing more than 1600 highly-skilled and motivated professionals globally, APOTEX PHARMACHEM has multiple facilities around the world including Canada (Apotex Pharmachem Canada), India (Srini Pharmaceutical LTD.), Mexico (Signa), and China.

APOTEX PHARMACHEM's capabilities allow delivery of your product requirements on schedule through a comprehensive suite of API services. The company's expert core teams deliver on our customer’s needs for proprietary API processes and manufacturing requirements, novel API salt and crystalline forms, intellectual property protection, analytical chemistry services, technology transfer, regulatory affairs and API registration, quality and compliance, and more.

Over 667 Drug Master Files in Common Technical Document (CTD) format have been prepared and filed by our highly qualified and experienced regulatory affairs teams and DMF submissions have been made in over 49 countries covering more than 118 API's. APOTEX PHARMACHEM'S jurisdictional knowledge and coverage includes the United States, EU (EU Countries) - CEP/MRP, Canada, Australia, Japan, Brazil, Russia, and China. Back To Top

BIOINDUSTRIA, Italy

BIOINDUSTRIA L.I.M. was founded in 1932. The company is now able to offer both a large range of finished active ingredients in bulk for the pharmaceutical industry and the development of specialized custom synthesis for "highly demanding" customers.

The activities of the company are:

  • Production of large volume I.V. Solutions
  • Production of Generics
  • Manufacturing and marketing of bulk active ingredients for the pharmaceutical industry
  • Manufacturing and marketing of flavours and fragrances

All products are supported by DMF's that are filed in house by BIOINDUSTRIA L.I.M. staff.

BIOINDUSTRIA'S Quality System has been recognized by the FDA as well as many successful audits by major Italian and foreign pharmaceutical companies and their respective countries' Health Authority. BIOINDUSTRIA L.I.M. is always accessible to customer's audits. Back To Top

CHR. OLESEN GROUP, Denmark

CHR. OLESEN GROUP is a distribution and sales company with five sectors including: feed, food, pharma, intermediates and veterinary pharmaceuticals. The company serves customers all over the world via their network of subsidiaries and strategically placed warehouses. CHR. OLESEN GROUP is based in Copenhagen and has subsidiaries in Belgium, USA, and Germany.

CHR. OLESEN GROUP has three basic principles that drive their business which include correct product quality, optimal pricing and timely delivery. The company works exclusively with selected principal manufacturers that have proven to consistently meet the standards and demands of different markets. CHR. OLESEN GROUP has developed a quality control system to ensure that products are compliant with the required standards.

In terms of pharmaceuticals, CHR. OLESEN PHARMACEUTICALS is located in Gentofte, Denmark and the subsidiary of CHR. OLESEN GROUP focuses on supplying active pharmaceutical ingredients of the international pharmaceutical industry. Back To Top

CORDEN PHARMA INTERNATIONAL, Germany

Formed as a pharmaceutical branch of International Chemical Investors Group in 2006, CordenPharma provides specialised technologies that are ideal for the development and manufacturing of oral, sterile, highly potent and antibiotic pharmaceutical Drug Products, their Active Pharmaceutical Ingredients, and associated Global Supply Chain and Packaging Services. 

CordenPharma is committed to providing flexible solutions for your product success through a legacy of combined API development and contract manufacturing capabilities and specialised technologies in state-of-the-art cGMP facilities. Back To Top

ELPEN Pharmaceutical Co. Inc., Greece

ELPEN was established in 1969 and is the leader among purely Greek pharmaceutical companies. The vision of the company is to offer high quality pharmaceuticals for the treatment of disease while striving to effectively contribute to the community and to the Greek economy.

ELPEN specializes in branded generics, and original pharmaceuticals obtained through many collaborations with multinational companies. ELPEN factory headquarters located at Pikermi, Attica, currently covers an area of approximately 10,000 m² in terms of building facilities, on a plot extending over 15,000 m². The company implements strict regulations regarding quality control and quality assurance to ensure successful service.

The goal for ELPEN is to expand their presence in the world, starting with the Balkan countries and moving on to Europe, by taking advantage of Greece's strategic, geographical position, and the company's extensive and innovative product portfolio. Back To Top

FORMOSA LABORATORIES, Taiwan

FORMOSA LABORATORIES, INC. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosa’s major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, Formosa's UV-filter products include avobenzone and Octinoxate. The company also provides custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.

Process development and route optimization are core competencies of Formosa's business. The company has a dedicated staff of professional process chemists and engineers with significant experience and expertise in the development of robust cGMP chemical processes. Back To Top

GRINDEKS, Latvia

GRINDEKS was founded in 1991 with Latvian independence and was then turned into a Public Joint Stock Company in 1997.

The main fields of action for GRINDEKS are research, development, manufacturing, and sales of original products, generics, and active pharmaceutical ingredients. GRINDEKS specializes in cardiovascular, CNS, and anti-cancer therapy.

GRINDEKS consists of 4 subsidiary companies in Latvia, Estonia and Russia, and has representative offices in 11 countries. The central office for GRINDEKS is located in Riga, Latvia and is responsible for monitoring, governance, and management of the entire GRINDEKS company.

GRINDEKS is an innovative company that focuses on customer satisfaction, employee welfare, and environmentally friendly operations. GRINDEKS has significant future growth potential. Back To Top

IASIS PHARMACEUTICALS HELLAS S.A., Greece

IASIS PHARMACEUTICALS HELLAS S.A. is a Greek pharmaceutical company that is active in the production, research and development, import, export, and trade of pharmaceutical products. The company is the result of a merger between Chemipharma Pachis Ltd. and Farmanic Ltd..

IASIS PHARMA produces their products in facilities that adhere to international standards. The company focuses on non-prescription medicines, medical devices, and over-the-counter products.

IASIS PHARMA is a growing Greek pharmaceutical company that hopes to expand its presence internationally, to increase its portfolio of products offered, and to invest in biotechnology. Back To Top

ICROM

ICROM SpA was established in 1969 and in 1996 was acquired by the French chemical group Proxis Developpement SA. The company is located in Concorezzo, Milano, Italy. ICROM specializes in manufacturing active pharmaceutical ingredients and intermediates with GMP compliant facilities.

ICROM 's modern GMP manufacturing  facilities comprise of several units. Two units are dedicated to manufacture active pharmaceutical ingredients and intermediates. A third unit (KILOLAB) is dedicated to the production of small scale, high value products, usually contract manufacturing, custom synthesis projects. A fourth unit includes a full glove-boxed area which is devoted to small scale manufacturing of niche high-potency API's. The facilities are regularly inspected by the Italian Regulatory Authority (AIFA). All operating processes are duly GMP certified.

ICROM operations are  based on broad experience in applying its own technologies as well as  the technologies developed by its sister company FAR CHEMICAL, Inc. to serve worldwide pharmaceutical outsourcing.

The Quality Control Program conforms with all major international standards. It  is staffed by experienced and qualified chemists to guarantee the highest quality level of products.

Back To Top

IRIX PHARMACEUTICALS INC., United States

IRIX PHARMACEUTICALS INC. was founded in 1996 and is located in South Carolina, United States. The company is a privately held company engaged in the generation of process technology for new and existing drugs. IRIX offers the full capability of supplying API’s and complex pharma intermediates from pre-clinical stages, through all phases of clinical trials, registration/validation batches, launch and ongoing commercial quantities. 

IRIX operates three sites for Process R&D and Clinical through Commercial cGMP production of API’s. Process R&D and early stage clinical supply for API’s is based in Florence, South Carolina. This facility is smaller-scale with equipment that measures up to 2,000 L. Late-stage clinical supply and commercial production is located in Greenville, South Carolina. This facility is large-scale with equipment measuring up to 24,000 L. 

IRIX's client base includes North America, Europe, Asia and Australia. IRIX ensures compliance with all regulatory and quality requirements internationally. Both the Greenville and Florence site were visited by the FDA in 2008 and 2009, respectively, with no 483s issued for either site. IRIX has been a reliable and trusted partner of the health care industry with a history of proven government regulatory compliance for well over a decade. Their outstanding FDA inspection record is a reflection of their focus on quality. Back To Top

NCPC

NCPC (North China Pharmaceutical Group Corporation) was established in 1953 and is a leader in global antibiotic technology and production. Products include antibiotic bulks and formulations, vitamins and nutrition products, biotech products, immunosuppressants, pesticides, and veterinary drugs.

Development of bio-pharmacy is NCPC’s new strategic orientation and by utilizing its technological advantages accumulated in the field of traditional fermentation (antibiotics) since 1984, NCPC has initiated modern biotech research and set up a bio-tech drugs development system involving new product R&D, pilot scale, and industrialization. Back To Top

NOVOCAT FARMA S.A., Spain

NOVOCAT FARMA was founded in 1983 and is located in Barcelona, Spain. It is a private pharmaceutical company that is focused on the development and licencing of pharmaceutical products.

NOVOCAT FARMA has a long history in generics and is currently one of the largest generic development companies in Europe with a development pipeline of twenty generic molecules per year.

NOVOCAT FARMA manufactures its products in laboratories that are GMP compliant. The company has strategic partnerships with many EU states as well other international countries. NOVOCAT FARMA considers the requirements of every market and can supply a wide portfolio of valued products. Back To Top

SAVIOR LIFETEC CORPORATION, Taiwan

SAVIOR LIFETEC was founded in 2004 and is headquartered in Chunan Science Park, Taiwan. SAVIOR LIFETEC specializes in sterile carbapenem antibiotics, supplying high quality Active Pharmaceutical Ingredients to the pharmaceutical community. The company is dedicated to meeting ICH guidelines in its API development and production areas.

SAVIOR LIFETEC owns two high quality R&D centers and manufacturing facilities that cover 20,000 square meters in total:

  • Chunan Science Park is located in Northern Taiwan. This location includes the headquarters, an R&D center, one pilot plant, two large-scale plants, and two sterile plants.
  • Tainan Science Park is located in Southern Taiwan. This location includes an R&D center, three sterile plants, two pilot plants, and four large-scale plants. 

SAVIOR LIFETEC has over 550 highly experienced employees in its many departments. The company's qualified teams and high-performance instruments allow it to efficiently carry out lab-to-market development for complex processes and API's. Back To Top

SIGNA, Mexico

SIGNA is an Active Pharmaceutical Ingredients company located in Toluca, Estado de Mexico, 40 miles west of Mexico City.

SIGNA, along with Apotex Pharmachem Inc., Apotex Pharmachem India (PVT) LTD., Apotex Pharmachem (Tianjin) Inc., Apotex Fermentation Inc., Blue Treasure and Srini Pharmaceuticals Ltd, are the companies that together form the Apotex Pharmachem Group.

SIGNA's multiproduct and multipurpose cGMP facility has four productive plants and a total reaction capacity of 94,800 gal. The range of volumetric capacity ranges from 300 to 3,000 gal. The plant has the capacity to produce 35-40 different final products and their intermediates. SIGNA, along with Apotex Pharmachem Group's other companies, is US-FDA inspected and approved. The plant was also designated a "Clean Industry" by the Mexican Environmental Protection Agency due to their commitment in integrating safety, health, and environmental practices into their business activities. Back To Top

SYSTEMATIX, Canada

SYSTEMATIX, a Canadian company located in Waterloo, Ontario, is ACIC's exclusive partner for premier service, design, and manufacturing of turn-key factory automation systems for the pharmaceutical, medical device, cosmetics, and personal care industries.Together, ACIC and Systematix partner with clients around the world to provide them with custom automated manufacturing solutions to meet their most challenging assembly, test, machine vision, and material handling processes. Healthcare requires factory automation that is stable, easily validated, and error proof. Systematix’ expertise in this industry is based on collaboration with some of the world's largest and most demanding companies in device assembly and pharmaceutical packaging systems. Back To Top

THEMIS MEDICARE, India

Themis Medicare was founded in 1969 and is located in Mumbai, India. Themis Medicare is a joint venture with Gedeon Richter Ltd. located in Hungary.

Themis Medicare is a manufacturer of Active Pharmaceutical Ingredients and Formulations. The company caters to therapeutic areas such as antituberculosis, antimalarials, cardiology, pain management, anti-infectives, haematinics, and Health and Nutrition. The company has four state-of-the-art manufacturing facilities at three locations in Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).

Themis Medicare has a presence in 40 countries across the world. With a balanced geographical presence and a strong product flow from a wide therapeutic range, the company hopes to expand further into international markets including Europe, the Americas, and Australia. Back To Top

VIWIT PHARMACEUTICAL CO. LTD., China

VIWIT PHARMACEUTICAL CO. LTD. is a pharmaceutical and chemical enterprise that was founded in 2006. There is a research and development centre located in Shanghai, China as well as a Commercial Plant located in Shadong, China. VIWIT is dedicated to the development, manufacture and marketing of products in pharmaceuticals, nutraceuticals, agrochemicals, performance materials and alternative fuels. VIWIT has technological resources in asymmetric synthesis, organometallic chemistry, highly-active boron and phosphorus chemistry, and multi-step synthesis.

VIWIT's products and services are served to customers and partners in Asia, Europe, North America and South America. VIWIT's vision is to become a global leader in the development and commercialization of pharmaceuticals and fine chemicals.

VIWIT values integrity, candor, dedication to customer satisfaction, team work, continuous improvement, and efficient execution in all of the work they do. VIWIT also values sustainability within areas including environment, suppliers, products, technologies, and employees. Back To Top

ZACH SYSTEM, Italy

ZACH SYSTEM was established in 2007 and is headquartered in Bresso (MI), Italy. ZACH SYSTEM is the fine chemicals subsidiary of ZAMBON COMPANY S.p.A (est. 1906).

ZACH SYSTEM is a fine chemicals company to providing its customers with fast, cost-effective, quality custom synthesis services, API's and intermediates. The company also provides support supporting them with extensive process development expertise.

ZACH SYSTEM has two cGMP production facilities located in Lonigo, Italy and Avrillè, France. In addition to their manufacturing capabilities, each facility also contains dedicated R&D and commercial activities covering both Custom synthesis and Generic API production.

As a subsidiary of the holding company Zambon Company S.p.A., ZACH SYSTEM continues to offer complementary pharmaceutical services while enjoying the stability that comes from being part of a leading multinational company that has been in business for over 100 years. Back To Top